SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?


To: Emec who wrote (3446)3/31/1998 10:27:00 AM
From: Bradpalm1  Respond to of 34592
 
If anybody is considering SciClone (SCLN) to pop due to recent news, forget it. Zadaxin is a product still looking for a disease to treat. Studies of efficacy for treatment of Hepatitis B & C are unimpressive thus far and role in treatment of liver cancer are very preliminary.

Bradpalm1



To: Emec who wrote (3446)3/31/1998 10:27:00 AM
From: Rande Is  Read Replies (2) | Respond to of 34592
 
Calgary exchange? Quite a drive from Nashville. Hey, you'd think with 3 real time sources, one of them would show trades on PEAFF. I wonder if Farsight sent my order by way of Pony Express.

Rande Is

PS> PRWT Anyone's feeling on this nanocap?



To: Emec who wrote (3446)3/31/1998 10:36:00 AM
From: Sandra  Respond to of 34592
 
Dave
NPRO might have some legs....heres the scoop

10:13 ET NaPro BioTherapeutics (NPRO) 2 13/16 +5/16: Company issued a
patent relating to a novel method of stabilizing formulations of paclitaxel. By
receiving the patent, company triggers an additional $3.75 million payment from
IVAX, which is approx. equal to company's entire top-line in FY97 ($3.8 mln).